Al Raschdorf

Al Raschdorf is CTO of Opus Medical Therapies. Al was previously Chief Therapy Officer at Caisson Interventional (acquired by Livanova). Prior to Caisson, Al was an early engineer at eValve (aquired by Abbott Vascular). While at Abbott, Al supported Mitraclip cases around the world and was country manager of Italy. Al has a BSME from Cornell University, a MSME from Standford University and is a named inventor on 20+ patents.